Global RSV Vaccine Market Size, Share, and COVID-19 Impact Analysis, By Types of Vaccine (Subunit / Viral-like-Particle (VLP) Vaccines, Live Attenuated Vaccines, and mRNA Vaccines), By Distribution Channel (Pharmacies and Drug Stores, Government / Institutional Suppliers and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE May 2025
REPORT ID SI11001
PAGES 240
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Type of Vaccine
      2. Market Attractiveness Analysis By Distribution Channel
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increase High Incidence and Severity
    3. Restraints
      1. High Development Costs
    4. Opportunities
      1. High Disease Burden
    5. Challenges
      1. Efficacy and Duration of Protection
  6. Global RSV Vaccine Market Analysis and Projection, By Type of Vaccine
    1. Segment Overview
    2. Subunit / Viral-like-Particle (VLP) Vaccines
    3. Live Attenuated Vaccines
    4. mRNA Vaccines
  7. Global RSV Vaccine Market Analysis and Projection, By Distribution Channel
    1. Segment Overview
    2. Pharmacies and Drug Stores
    3. Government / Institutional Suppliers
    4. Others
  8. Global RSV Vaccine Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global RSV Vaccine Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Global RSV Vaccine Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Pfizer Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Moderna Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Sanofi 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Novavax Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   AstraZeneca plc 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Merck & Co. Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   GlaxoSmithKline
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Beijing Advaccine Biotechnology
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  GlaxoSmithKline plc (GSK)
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  2. Global Subunit / Viral-like-Particle (VLP) Vaccines, Global RSV Vaccine Market, By Region, 2024-2034(USD Billion)
  3. Global Live Attenuated Vaccines, Global RSV Vaccine Market, By Region, 2024-2034(USD Billion)
  4. Global mRNA Vaccines, Global RSV Vaccine Market, By Region, 2024-2034(USD Billion)
  5. Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  6. Global Pharmacies and Drug Stores, Global RSV Vaccine Market, By Region, 2024-2034(USD Billion)
  7. Global Government / Institutional Suppliers, Global RSV Vaccine Market, By Region, 2024-2034(USD Billion)
  8. Global Others, Global RSV Vaccine Market, By Region, 2024-2034(USD Billion)
  9. North America Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  10. North America Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  11. U.S.  Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  12. U.S.  Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  13. Canada Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  14. Canada Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  15. Mexico Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  16. Mexico Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  17. Europe Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  18. Europe Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  19. Germany Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  20. Germany Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  21. France Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  22. France Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  23. U.K.  Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  24. U.K.  Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  25. Italy Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  26. Italy Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  27. Spain Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  28. Spain Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  29. Asia Pacific Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  30. Asia Pacific Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  31. Japan Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  32. Japan Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  33. China Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  34. China Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  35. India Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  36. India Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  37. South America Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  38. South America Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  39. Brazil Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  40. Brazil Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  41. The Middle East and Africa Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD   Billion)
  42. The Middle East and Africa Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD   Billion)
  43. UAE Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  44. UAE Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)
  45. South Africa Global RSV Vaccine Market, By Type of Vaccine, 2024-2034(USD Billion)
  46. South Africa Global RSV Vaccine Market, By Distribution Channel, 2024-2034(USD Billion)

 

List of Figures 

  1. Global RSV Vaccine market segmentation
  2. Global RSV Vaccine Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Global RSV Vaccine Market
  9. Top Winning Strategies, 2024-2034
  10. Top Winning Strategies, By Development, 2024-2034(%)
  11. Top Winning Strategies, By Company, 2024-2034
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Global RSV Vaccine Market
  20. Global RSV Vaccine Market Segmentation, By Type of Vaccine
  21. Global RSV Vaccine Market For Subunit / Viral-like-Particle (VLP) Vaccines, By Region, 2024-2034 ($ Billion)
  22.  Global RSV Vaccine Market For Live Attenuated Vaccines, By Region, 2024-2034 ($ Billion)
  23. Global RSV Vaccine Market For mRNA Vaccines, By Region, 2024-2034 ($ Billion)
  24.  Global RSV Vaccine Market Segmentation, By Distribution Channel
  25.  Global RSV Vaccine Market For Pharmacies and Drug Stores, By Region, 2024-2034 ($ Billion)
  26.  Global RSV Vaccine Market For Government / Institutional Suppliers, By Region, 2024-2034 ($ Billion)
  27. Global RSV Vaccine Market For Others, By Region, 2024-2034 ($ Billion)
  28. Pfizer Inc.: Net Sales, 2024-2034 ($ Billion)
  29. Pfizer Inc.: Revenue Share, By Segment, 2024 (%)
  30. Pfizer Inc.: Revenue Share, By Region, 2024 (%)
  31. Moderna Inc.: Net Sales, 2024-2034 ($ Billion)
  32. Moderna Inc.: Revenue Share, By Segment, 2024 (%)
  33. Moderna Inc.: Revenue Share, By Region, 2024 (%)
  34. Sanofi: Net Sales, 2024-2034 ($ Billion)
  35. Sanofi: Revenue Share, By Segment, 2024 (%)
  36. Sanofi: Revenue Share, By Region, 2024 (%)
  37. Novavax Inc.: Net Sales, 2024-2034 ($ Billion)
  38. Novavax Inc.: Revenue Share, By Segment, 2024 (%)
  39. Novavax Inc.: Revenue Share, By Region, 2024 (%)
  40. AstraZeneca plc: Net Sales, 2024-2034 ($ Billion)
  41. AstraZeneca plc: Revenue Share, By Segment, 2024 (%)
  42. AstraZeneca plc: Revenue Share, By Region, 2024 (%)
  43. Merck & Co. Inc.: Net Sales, 2024-2034 ($ Billion)
  44. Merck & Co. Inc.: Revenue Share, By Segment, 2024 (%)
  45. Merck & Co. Inc.: Revenue Share, By Region, 2024 (%)
  46. GlaxoSmithKline: Net Sales, 2024-2034 ($ Billion)
  47. GlaxoSmithKline: Revenue Share, By Segment, 2024 (%)
  48. GlaxoSmithKline: Revenue Share, By Region, 2024 (%)
  49. Beijing Advaccine Biotechnology: Net Sales, 2024-2034 ($ Billion)
  50. Beijing Advaccine Biotechnology: Revenue Share, By Segment, 2024 (%)
  51. Beijing Advaccine Biotechnology: Revenue Share, By Region, 2024 (%)
  52. GlaxoSmithKline plc (GSK).: Net Sales, 2024-2034 ($ Billion)
  53. GlaxoSmithKline plc (GSK).: Revenue Share, By Segment, 2024 (%)
  54. GlaxoSmithKline plc (GSK).: Revenue Share, By Region, 2024 (%)
  55. Others: Net Sales, 2024-2034 ($ Billion)
  56. Others: Revenue Share, By Segment, 2024 (%)
  57. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:120
Pages:240
Countries covered:20
Companies covered::18
Forecast CAGR:5.14%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies